You searched for "regulation"
Triamcinolone (TA) deposits following subcutaneous injection to treat chalazion
Chalazia are chronic lipogranulomatous inflammations of the eyelid secondary to a blocked meibomian gland. Whilst most resolve spontaneously, certain chalazia warrant treatment. Options include incision and curettage (I&C), lesion excision, intralesional steroid injections, and botox injections [1]. I&C is usually...WATCH: Beyond 2020 with the Andean Medical Mission
This Andean Medical Mission series is called Beyond 2020, and focuses on the many aspects of creating services which will ultimately impact on eliminating avoidable blindness in countries with developing eyecare services.Specsavers joins IAPB to advocate for better eye health
The International Agency for the Prevention of Blindness (IAPB) proudly welcomes Specsavers as a pivotal new member, joining the global alliance for the eye health sector in the fight against avoidable sight loss. "For more than four decades, Specsavers has...
Transcriptomic analysis of ocular tissues
Transcriptomics is defined as the analysis of the complete set of RNA transcripts present in a cell under different circumstances, quiescent versus challenge, by microarray analysis. Comparison of transcriptomes identifies genes that are differentially expressed in different cell populations under...
Atropine treatment for myopia in western countries – rationale
This preliminary study sets out the rationale, methodology and participant baseline characteristics for the Western Australia Atropine for the Treatment of Myopia (WA-ATOM). It is a double masked randomised placebo-controlled trial. This study is designed to be combined with the...
Treat-and-extend regimen in treatment of patients with type 3 neovascularisation
Type 3 neovascularisation, also known as retinal angiomatous proliferation is a distinct subtype of neovascular AMD characterised by intraretinal neovascularisation. This retrospective study included 17 eyes diagnosed with type 3 neovascularisation who were changed from pro-re-nata (PRN) based treatment regime...
Exploring the potential of neurodegenerative disease screening within age-related eye disease research
The authors recruited healthy controls aged between 60 and 75-years-old, previously enrolled into a registry as patients following cataract surgery without age-related macular degeneration (AMD). Exclusion criteria included dense cataract, retinal disease, ocular inflammatory disease, moderate glaucoma, optic neuropathy, cancer,...WATCH: Beyond 2020 with the Andean Medical Mission
This Andean Medical Mission series is called Beyond 2020, and focuses on the many aspects of creating services which will ultimately impact on eliminating avoidable blindness in countries with developing eyecare services.
